In 2025, biopharma layoffs showed no signs of slowing, instead rising 16% year over year.
Espace publicitaire · 300×250
Espace publicitaire · 728×90
Articles similaires
🇬🇧 → 🇫🇷
Chutes & Ladders—Former Roche oncology head turns to Tubulis
...
🇬🇧 → 🇫🇷
Baby KJ scientist launches personalized CRISPR therapy startup
A 25-year-old biologist is launching a new company with $3.4 million in seed funding to develop a personalized cell therapy using the gene-editing tool CRISPR.
🇬🇧 → 🇫🇷
Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
Quanterix has a new chief executive and president in Everett Cunningham, but analysts at Leerink see Illumina’s former commercial chief facing an uphill battle in his bid to turn the medtech’s fortunes around.
🇬🇧 → 🇫🇷
Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Madrigal paid Pfizer $50 million for the rights to a DGAT2i inhibitor that the biopharma intends to combine with its approved liver disease drug Rezdiffra.
🇬🇧 → 🇫🇷
AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
AirNexis Therapeutics is taking flight with $200 million and a clinical-stage asset from a China pharma that aims to treat lung disease.
🇬🇧 → 🇫🇷
Orca rides $250M funding wave toward cancer cell therapy launch
Orca Bio has disclosed $250 million in funding, flooding its balance sheet with cash to buoy preparations for the commercialization of a blood cancer cell therapy.
🇬🇧 → 🇫🇷
3 new venture funds collect nearly $1B for biotech in US, EU
The new year has ushered in a flow of biotech-specific funds, including $700 million from Andreessen Horowitz.
🇬🇧 → 🇫🇷
Illumina hires former NHGRI Director Eric Green as new chief medical officer
Nearly a year after leaving his position as longtime director of the National Human Genome Research Institute, Eric Green, M.D., Ph.D., will now step into the commercial life sciences world as the new chief medical officer of Illumina.